MeSH tree: E05.200.500.384.100.580
Skipping sentinel lymph node biopsy (SLNB) in patients with clinically node-negative, hormonal receptor (HR)-positive, HER2-negative early-stage breast cancer did not compromise regional control or survival after a median ...
Dec 11, 2025
0
10
For patients with early-stage cervical cancer, sentinel lymph node biopsy alone is noninferior to lymphadenectomy with respect to disease-free survival, according to a study published online Oct. 15 in the New England Journal ...
Oct 23, 2025
0
10
A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for cancer in their lymph nodes—a finding that could guide treatment decisions and help many people ...
Oct 22, 2025
0
10
Removing lymph nodes during cancer surgery has saved countless lives in many tumor types. Yet recent research is challenging parts of this long-standing practice.
Sep 29, 2025
0
10
A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyzes previously unutilized information in mammograms and pinpoints ...
Sep 17, 2025
0
17
While melanoma is much less common than other types of skin cancer, it is the most serious because it is more likely to metastasize, or spread, to other parts of the body.
Feb 12, 2025
0
12
Omission of surgical axillary staging is noninferior to sentinel-lymph-node biopsy for patients with clinically node-negative, T1 or T2 invasive breast cancer, according to a study published online Dec. 12 in the New England ...
Dec 13, 2024
0
34
Some early breast cancer patients can safely avoid specific surgeries, according to two studies exploring ways to lessen treatment burdens.
Dec 12, 2024
0
14
University of Pittsburgh and UPMC Hillman Cancer Center researchers have developed a novel prompt, or 'nudge' embedded in the electronic health record that flags, for treating surgeons, older patients with early-stage breast ...
Jul 17, 2024
0
43
Surgery involving sentinel lymph node biopsy for middle-aged women with estrogen receptor-positive (ER+) breast cancer may do more harm than good, according to a new study led by University of Pittsburgh and UPMC Hillman ...
May 22, 2024
0
56
